BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

382 related articles for article (PubMed ID: 27626707)

  • 1. Therapeutic target discovery and drug development in cancer stem cells for leukemia and lymphoma: from bench to the clinic.
    Laranjeira AB; Yang SX
    Expert Opin Drug Discov; 2016 Nov; 11(11):1071-1080. PubMed ID: 27626707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting Notch, Hedgehog, and Wnt pathways in cancer stem cells: clinical update.
    Takebe N; Miele L; Harris PJ; Jeong W; Bando H; Kahn M; Yang SX; Ivy SP
    Nat Rev Clin Oncol; 2015 Aug; 12(8):445-64. PubMed ID: 25850553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting cancer stem cells by inhibiting Wnt, Notch, and Hedgehog pathways.
    Takebe N; Harris PJ; Warren RQ; Ivy SP
    Nat Rev Clin Oncol; 2011 Feb; 8(2):97-106. PubMed ID: 21151206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Approaches for targeting self-renewal pathways in cancer stem cells: implications for hematological treatments.
    Horne GA; Copland M
    Expert Opin Drug Discov; 2017 May; 12(5):465-474. PubMed ID: 28277836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug discovery approaches to target Wnt signaling in cancer stem cells.
    Curtin JC; Lorenzi MV
    Oncotarget; 2010 Nov; 1(7):563-577. PubMed ID: 21317452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery and characterization of a potent Wnt and hedgehog signaling pathways dual inhibitor.
    Ma H; Chen Q; Zhu F; Zheng J; Li J; Zhang H; Chen S; Xing H; Luo L; Zheng LT; He S; Zhang X
    Eur J Med Chem; 2018 Apr; 149():110-121. PubMed ID: 29499483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Novel signal transduction pathways: the molecular basis for targeted cancer therapies in Hedgehog/Notch/Wnt pathway].
    Shimizu T; Nakagawa K
    Nihon Rinsho; 2015 Aug; 73(8):1342-8. PubMed ID: 26281688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Eliminating Cancer Stem Cells by Targeting Embryonic Signaling Pathways.
    Oren O; Smith BD
    Stem Cell Rev Rep; 2017 Feb; 13(1):17-23. PubMed ID: 27730468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of combination of notch inhibitor plus hedgehog inhibitor or Wnt inhibitor on growth of leukemia cells.
    Okuhashi Y; Itoh M; Nara N; Tohda S
    Anticancer Res; 2011 Mar; 31(3):893-6. PubMed ID: 21498710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting stem cell signaling pathways for drug discovery: advances in the Notch and Wnt pathways.
    An SM; Ding Q; Zhang J; Xie J; Li L
    Sci China Life Sci; 2014 Jun; 57(6):575-80. PubMed ID: 24829106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of Small Molecules Targeting the Wnt Signaling Pathway in Cancer Stem Cells for the Treatment of Colorectal Cancer.
    Song L; Li Y; He B; Gong Y
    Clin Colorectal Cancer; 2015 Sep; 14(3):133-45. PubMed ID: 25799881
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blocking the NOTCH pathway can inhibit the growth of CD133-positive A549 cells and sensitize to chemotherapy.
    Liu J; Mao Z; Huang J; Xie S; Liu T; Mao Z
    Biochem Biophys Res Commun; 2014 Feb; 444(4):670-5. PubMed ID: 24502949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Self-Renewal and Pluripotency in Osteosarcoma Stem Cells' Chemoresistance: Notch, Hedgehog, and Wnt/β-Catenin Interplay with Embryonic Markers.
    Martins-Neves SR; Sampaio-Ribeiro G; Gomes CMF
    Int J Mol Sci; 2023 May; 24(9):. PubMed ID: 37176108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic Potential, Challenges and Future Perspective of Cancer Stem Cells in Translational Oncology: A Critical Review.
    Shukla G; Khera HK; Srivastava AK; Khare P; Patidar R; Saxena R
    Curr Stem Cell Res Ther; 2017; 12(3):207-224. PubMed ID: 27804866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer stem cell (CSC) inhibitors: a review of recent patents (2012-2015).
    Kharkar PS
    Expert Opin Ther Pat; 2017 Jul; 27(7):753-761. PubMed ID: 28460551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Morphogen pathways as molecular targets for the treatment of fibrosis in systemic sclerosis.
    Beyer C; Dees C; Distler JH
    Arch Dermatol Res; 2013 Jan; 305(1):1-8. PubMed ID: 23208311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel therapeutic strategies for targeting liver cancer stem cells.
    Oishi N; Wang XW
    Int J Biol Sci; 2011 Apr; 7(5):517-35. PubMed ID: 21552419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting cancer stem cells by using the nanoparticles.
    Hong IS; Jang GB; Lee HY; Nam JS
    Int J Nanomedicine; 2015; 10(Spec Iss):251-60. PubMed ID: 26425092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular pathways: novel approaches for improved therapeutic targeting of Hedgehog signaling in cancer stem cells.
    Justilien V; Fields AP
    Clin Cancer Res; 2015 Feb; 21(3):505-13. PubMed ID: 25646180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Wnt signaling as potential therapeutic target in lung cancer.
    Yang J; Chen J; He J; Li J; Shi J; Cho WC; Liu X
    Expert Opin Ther Targets; 2016 Aug; 20(8):999-1015. PubMed ID: 26882052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.